-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

T-cell–based Therapies for Treating Relapsed or Refractory Mantle Cell Lymphoma

Program: Education Program
Session: A Shifting Landscape: Treatment of MCL
Hematology Disease Topics & Pathways:
Research, Clinical trials, Clinical Practice (Health Services and Quality), Clinical Research, Real-world evidence
Monday, December 9, 2024, 10:30 AM-11:45 AM

Lia Palomba, MD

Memorial Sloan Kettering Cancer Center, New York, NY; Memorial Sloan Kettering, New York, NY; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Disclosures: Palomba: Novartis: Consultancy; Synthekine: Consultancy; Cellectar: Consultancy; Bristo Meyer Squibb: Consultancy.

OffLabel Disclosure:

See more of: A Shifting Landscape: Treatment of MCL
See more of: Education Program
<< Previous Presentation | Next Presentation